Publication | Open Access

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

Tyms Genetic VariantsOncologyOncogenic AgentMedicineFluorouracil Combination TherapyPathologyColorectal CancerColorectal Cancer PatientsCancer GenomicsCancer GeneticsPharmacology